|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis1 f8 B6 F( F! U. V d
was to close its brain research facility in Basel, Switzerland,
4 m# j: C* S7 \' [ U% ]the story noted that this move closely followed similar cuts
7 D1 e* b6 r/ }4 G+ o$ b6 pby rival pharmaceutical firms. As a report from the European College
1 @/ n; x" r1 {4 y* d; Eof Neuropsychopharmacology' ~9 x/ C5 j! v( k
had warned a few months earlier, the
; b3 s+ i% a& [! b! Jabandonment of research into new psychiatric drugs by AstraZeneca,
0 g5 x e9 g6 @+ V2 wGlaxoSmithKline
k: d6 D, d2 i) |# Tand others meant that “withdrawal of research
# F! x3 d7 @ U, Q# K7 f* Yresources is a withdrawal of hope for patients and their families”.
F/ x1 P! i6 ?0 ?: e5 ~" {" a. {
! w2 x- v" V0 ~; }2 q" F% [
回复有免费下载链接
9 N) z0 L& G; Q% q* C
7 E" ~; g: P- b1 ? |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
